BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fossati P, Vavassori A, Deantonio L, Ferrara E, Krengli M, Orecchia R. Review of photon and proton radiotherapy for skull base tumours. Rep Pract Oncol Radiother 2016;21:336-55. [PMID: 27330419 DOI: 10.1016/j.rpor.2016.03.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Thawani R, Kim MS, Arastu A, Feng Z, West MT, Taflin NF, Thein KZ, Li R, Geltzeiler M, Lee N, Fuller CD, Grandis JR, Floudas CS, Heinrich MC, Hanna E, Chandra RA. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin 2022. [PMID: 35916666 DOI: 10.3322/caac.21752] [Reference Citation Analysis]
2 Gordon K, Gulidov I, Koryakin S, Smyk D, Makeenkova T, Gogolin D, Lepilina O, Golovanova O, Semenov A, Dujenko S, Medvedeva K, Mardynsky Y. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity. Radiat Oncol 2021;16. [DOI: 10.1186/s13014-021-01961-9] [Reference Citation Analysis]
3 Teng C, Yang Q, Xiong Z, Ye N, Li X. Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma. Front Surg 2021;8:764329. [PMID: 34888345 DOI: 10.3389/fsurg.2021.764329] [Reference Citation Analysis]
4 Singh P, Eley J, Mahmood N, Bhandary B, Dukic T, Tu KJ, Polf J, Lamichhane N, Mahmood J, Vujaskovic Z, Shukla HD. Therapeutic Efficacy of Variable Biological Effectiveness of Proton Therapy in U-CH2 and MUG-Chor1 Human Chordoma Cell Death. Cancers (Basel) 2021;13:6115. [PMID: 34885223 DOI: 10.3390/cancers13236115] [Reference Citation Analysis]
5 Rimmer RA, Mace JC, Andersen PE, Cetas JS, Ciporen JN, Dogan A, Smith TL, Geltzeiler M. Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database. Int Forum Allergy Rhinol 2021. [PMID: 34704402 DOI: 10.1002/alr.22909] [Reference Citation Analysis]
6 Köthe A, Feuvret L, Weber DC, Safai S, Lomax AJ, Fattori G. Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy. Cancers (Basel) 2021;13:5327. [PMID: 34771490 DOI: 10.3390/cancers13215327] [Reference Citation Analysis]
7 Gordon KB, Smyk DI, Gulidov IA. Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review). Sovrem Tekhnologii Med 2021;13:70-80. [PMID: 34603766 DOI: 10.17691/stm2021.13.4.08] [Reference Citation Analysis]
8 Sallabanda M, Garcia R, Lorenzana L, Santaolalla I, Abarca J, Sallabanda K. Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience. Cureus 2021;13:e17012. [PMID: 34405079 DOI: 10.7759/cureus.17012] [Reference Citation Analysis]
9 Hug EB, Pelak M, Frank SJ, Fossati P. A Review of Particle Therapy for Skull Base Tumors: Modern Considerations and Future Directions. Int J Part Ther 2021;8:168-78. [PMID: 34285944 DOI: 10.14338/IJPT-20-00083] [Reference Citation Analysis]
10 Ferrari M, Taboni S, Carobbio ALC, Emanuelli E, Maroldi R, Bossi P, Nicolai P. Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence. Cancers (Basel) 2021;13:2835. [PMID: 34200193 DOI: 10.3390/cancers13112835] [Reference Citation Analysis]
11 Nicholas O, Prosser S, Mortensen HR, Radhakrishna G, Hawkins MA, Gwynne SH. The Promise of Proton Beam Therapy for Oesophageal Cancer: A Systematic Review of Dosimetric and Clinical Outcomes. Clin Oncol (R Coll Radiol) 2021;33:e339-58. [PMID: 33931290 DOI: 10.1016/j.clon.2021.04.003] [Reference Citation Analysis]
12 Hashemi Z, Tatari M, Naik H. Simulation of dose distribution and secondary particle production in proton therapy of brain tumor. Rep Pract Oncol Radiother 2020;25:927-33. [PMID: 33088228 DOI: 10.1016/j.rpor.2020.08.015] [Reference Citation Analysis]
13 VanKoevering KK, Sabetsarvestani K, Sullivan SE, Barkan A, Mierzwa M, McKean EL. Pituitary Dysfunction after Radiation for Anterior Skull Base Malignancies: Incidence and Screening. J Neurol Surg B Skull Base 2020;81:75-81. [PMID: 32021753 DOI: 10.1055/s-0039-1679893] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Li Q, Yang R, Wang Y, Sun H, Wang H, Liu H, Guo Y, Guo C. MR imaging as a precise technique to evaluate skull-base tumor volume: Comparison of CT, MR imaging and FDG PET from murine and clinical data. Journal of Cranio-Maxillofacial Surgery 2020;48:105-10. [DOI: 10.1016/j.jcms.2019.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gutierrez A, Rompokos V, Li K, Gillies C, D'Souza D, Solda F, Fersht N, Chang YC, Royle G, Amos RA, Underwood T. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT. Acta Oncol 2019;58:1765-74. [PMID: 31429359 DOI: 10.1080/0284186X.2019.1653496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zanoletti E, Mazzoni A, Martini A, Abbritti RV, Albertini R, Alexandre E, Baro V, Bartolini S, Bernardeschi D, Bivona R, Bonali M, Borghesi I, Borsetto D, Bovo R, Breun M, Calbucci F, Carlson ML, Caruso A, Cayé-Thomasen P, Cazzador D, Champagne PO, Colangeli R, Conte G, D'Avella D, Danesi G, Deantonio L, Denaro L, Di Berardino F, Draghi R, Ebner FH, Favaretto N, Ferri G, Fioravanti A, Froelich S, Giannuzzi A, Girasoli L, Grossardt BR, Guidi M, Hagen R, Hanakita S, Hardy DG, Iglesias VC, Jefferies S, Jia H, Kalamarides M, Kanaan IN, Krengli M, Landi A, Lauda L, Lepera D, Lieber S, Lloyd SLK, Lovato A, Maccarrone F, Macfarlane R, Magnan J, Magnoni L, Marchioni D, Marinelli JP, Marioni G, Mastronardi V, Matthies C, Moffat DA, Munari S, Nardone M, Pareschi R, Pavone C, Piccirillo E, Piras G, Presutti L, Restivo G, Reznitsky M, Roca E, Russo A, Sanna M, Sartori L, Scheich M, Shehata-Dieler W, Soloperto D, Sorrentino F, Sterkers O, Taibah A, Tatagiba M, Tealdo G, Vlad D, Wu H, Zanetti D. Surgery of the lateral skull base: a 50-year endeavour. Acta Otorhinolaryngol Ital 2019;39:S1-S146. [PMID: 31130732 DOI: 10.14639/0392-100X-suppl.1-39-2019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
17 Guan X, Gao J, Hu J, Hu W, Yang J, Qiu X, Hu C, Kong L, Lu JJ. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiat Oncol 2019;14:206. [PMID: 31752953 DOI: 10.1186/s13014-019-1407-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
18 Zoia C, Lombardi F, Custodi VM, Lovati E, Lucotti P, Iannalfi A, D'ippolito E, Valvo F, Bongetta D. Evaluation of the early endocrinological sequelae after hadron therapy on anterior skull base lesions in the adult population. Minerva Endocrinol 2020;45:162-4. [PMID: 31738035 DOI: 10.23736/S0391-1977.19.03071-2] [Reference Citation Analysis]
19 Mohamed Ali A, Mathis T, Bensadoun RJ, Thariat J. Radiation induced optic neuropathy: Does treatment modality influence the risk? Bull Cancer 2019;106:1160-76. [PMID: 31757405 DOI: 10.1016/j.bulcan.2019.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
20 Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach. Laryngoscope 2020;130:857-65. [PMID: 31369156 DOI: 10.1002/lary.28202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 van Wulfften Palthe O, Jee KW, Bramer JAM, Hornicek FJ, Chen YE, Schwab JH. What Is the Effect of High-dose Radiation on Bone in Patients With Sacral Chordoma? A CT Study. Clin Orthop Relat Res 2018;476:520-8. [PMID: 29529635 DOI: 10.1007/s11999.0000000000000063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
22 Holtzman AL, Rotondo RL, Rutenberg MS, Indelicato DJ, Mercado CE, Rao D, Tavanaiepour D, Morris CG, Louis D, Flampouri S, Mendenhall WM. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study. J Neurooncol 2019;142:557-63. [PMID: 30827010 DOI: 10.1007/s11060-019-03129-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
23 Palm RF, Oliver DE, Yang GQ, Abuodeh Y, Naghavi AO, Johnstone PAS. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base. Cancer 2019;125:642-51. [PMID: 30644538 DOI: 10.1002/cncr.31958] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
24 van Koevering K, Prevedello DM, Carrau RL. Endoscopic endonasal approaches for the management of cranial base malignancies: histologically guided treatment and clinical outcomes. J Neurosurg Sci 2018;62:667-81. [PMID: 29808637 DOI: 10.23736/S0390-5616.18.04507-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Brahimi Y, Antoni D, Srour R, Proust F, Cebula H, Labani A, Noël G. [Base of the skull meningioma: Efficacy, clinical tolerance and radiological evaluation after radiotherapy]. Cancer Radiother 2018;22:264-86. [PMID: 29773473 DOI: 10.1016/j.canrad.2017.09.010] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Garibaldi C, Jereczek-Fossa BA, Marvaso G, Dicuonzo S, Rojas DP, Cattani F, Starzyńska A, Ciardo D, Surgo A, Leonardi MC, Ricotti R. Recent advances in radiation oncology. Ecancermedicalscience 2017;11:785. [PMID: 29225692 DOI: 10.3332/ecancer.2017.785] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
27 Li D, Weng JC, Zhang GJ, Hao SY, Tang J, Zhang LW, Wang L, Wu Z, Jia W, Zhang JT. Proposed Treatment Paradigm for Intracranial Chondrosarcomas Based on Multidisciplinary Coordination. World Neurosurg 2018;109:e517-30. [PMID: 29033377 DOI: 10.1016/j.wneu.2017.10.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
28 Murray FR, Snider JW, Bolsi A, Lomax AJ, Walser M, Kliebsch U, Schneider RA, Weber DC. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas. Int J Radiat Oncol Biol Phys 2017;99:1190-8. [PMID: 28939227 DOI: 10.1016/j.ijrobp.2017.08.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
29 Kulkarni BSN, Bajwa H, Chandrashekhar M, Sharma SD, Singareddy R, Gudipudi D, Ahmad S, Kumar A, Sresty NVNM, Raju AK. CT- and MRI-based gross target volume comparison in vestibular schwannomas. Rep Pract Oncol Radiother 2017;22:201-8. [PMID: 28461783 DOI: 10.1016/j.rpor.2017.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Combs SE. Does Proton Therapy Have a Future in CNS Tumors? Curr Treat Options Neurol 2017;19:12. [PMID: 28365895 DOI: 10.1007/s11940-017-0447-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]